Statin therapy reduces risk for diabetic retinopathy in T2DM

Statin therapy reduces risk for diabetic retinopathy in T2DM

(HealthDay)—For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according to a study published online Jan. 10 in JAMA Ophthalmology.

Eugene Yu-Chuan Kang, M.D., from the Chang Gung Memorial Hospital in Taoyuan, Taiwan, and colleagues examined the correlation between and development of diabetic retinopathy in patients with diabetes and dyslipidemia. After matching, 18,947 patients were included in the statin and nonstatin groups.

The researchers found that 10.6 and 12.0 percent of patients in the statin and nonstatin groups, respectively, developed diabetic retinopathy. Compared with the nonstatin group, the statin group had significantly lower rates of diabetic retinopathy, nonproliferative diabetic retinopathy, proliferative diabetic retinopathy, vitreous hemorrhage, tractional retinal detachment, and (hazard ratios, 0.86, 0.92, 0.64, 0.62, 0.61, and 0.60, respectively); they also had lower rates of interventions such as retinal laser treatment, intravitreal injection, and vitrectomy (hazard ratios, 0.71, 0.74, and 0.58, respectively) and underwent a smaller number of these interventions (rate ratios, 0.61, 0.68, and 0.54, respectively). A correlation was also noted for statin therapy with reduced risks for major adverse cardiovascular events, new-onset diabetic neuropathy, and new-onset diabetic foot ulcers (hazard ratio, 0.81, 0.85, and 0.73, respectively).

"These results suggest that statins are associated with a decreased prevalence of diabetic retinopathy and may decrease the progression of in patients with type 2 diabetes and dyslipidemia," the authors write.

More information: Abstract/Full Text (subscription or payment may be required)

Journal information: JAMA Ophthalmology

Copyright © 2019 HealthDay. All rights reserved.

Citation: Statin therapy reduces risk for diabetic retinopathy in T2DM (2019, January 11) retrieved 5 March 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Japanese study questions benefit of treat-to-target statin therapy in diabetic retinopathy


Feedback to editors